Hapvida (HAPV3) incurred a loss of R$182 million in the first quarter – Money Times

medical group and health insurance havid (HAPV3) The consolidated net loss amounted to 182 million riyals in the first quarter, which reflected the positive performance of 152 million riyals obtained in the previous year, according to a balance sheet issued on Monday.

The numbers include data from Notre Dame Intermedica (GDIN3), its Hapvida competitor merged in mid-February this year.

The company determined the operating result measured by profit before OutlayAnd taxesthe depreciation and amortization rate (Ebitda) of 414 million Omani riyals from January to March, down 11.3% in the annual comparison.

Analysts, on average, expected Hapvida to make an Ebitda bid of 713 million riyals, according to data from Refinitiv.

Hapvida shares were among the biggest decliners of the day, closing 2.2% lower. Ibovespa (IBOV) rose by 1.22%.

Total claims, an important performance indicator for a group of health plans, rose 11.3 percentage points in the quarter from a year earlier, to 76.9%.

The Intermedica Index stood at 83% looking at February and March while the Hapveda Index alone rose 5.9 points to 71.4%.

Receive newsletters from Money Times!

Subscribe to our newsletters and always be well informed with news that enriches your day! Money Times 8 brings in moderators who cover the main topics of the market. Register now And receive the information directly in your email. It’s free!